Quaternary Structure of Pathological Prion Protein as a Determining Factor of Strain-Specific Prion Replication Dynamics

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Laferrière, Florent ^a   Tixador, Philippe ^a,b   Moudjou, Mohammed ^a   Chapuis, Jérôme ^a   Sibille, Pierre ^a   Herzog, Laetitia ^a   Reine, Fabienne ^a   Jaumain, Emilie ^a   Laude, Hubert ^a   Rezaei, Human ^a   Béringue, Vincent ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITONIN; PRION PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY AGENT; IMMUNOBLOTTING; INCUBATION TIME; MOUSE; NONHUMAN; PRION; PROTEIN ANALYSIS; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; PROTEIN QUATERNARY STRUCTURE; SCRAPIE AGENT; SEDIMENTATION RATE; VIRUS ASSEMBLY; VIRUS INFECTIVITY; VIRUS REPLICATION;

ANIMALS; MICE; MICE, TRANSGENIC; PRION DISEASES; PROTEIN STRUCTURE, QUATERNARY; PRPSC PROTEINS; SHEEP; SPECIES SPECIFICITY; TIME FACTORS;

EID: 84887275537     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003702     Document Type: Article

References (84)

1. Colby DW, Prusiner SB, (2011) Prions. Cold Spring Harb Perspect Biol 3: a006833.
2. Bemporad F, Chiti F, (2012) Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. Chem Biol 19: 315-327.
3. Diaz-Espinoza R, Soto C, (2012) High-resolution structure of infectious prion protein: the final frontier. Nat Struct Mol Biol 19: 370-377.
4. Wadsworth JD, Collinge J, (2007) Update on human prion disease. Biochim Biophys Acta 1772: 598-609.
5. Prusiner SB, (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
6. Knowles TP, Waudby CA, Devlin GL, Cohen SI, Aguzzi A, et al. (2009) An analytical solution to the kinetics of breakable filament assembly. Science 326: 1533-1537.
7. Xue WF, Homans SW, Radford SE, (2008) Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci U S A 105: 8926-8931.
8. Colby DW, Prusiner SB, (2011) De novo generation of prion strains. Nat Rev Microbiol 9: 771-777.
9. Soto C, (2011) Prion hypothesis: the end of the controversy? Trends Biochem Sci 36: 151-158.
10. Collinge J, (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24: 519-550.
11. Bessen RA, Marsh RF, (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68: 7859-7868.
12. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274: 2079-2082.
13. Sim VL, Caughey B, (2009) Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol Aging 30: 2031-2042.
14. Spassov S, Beekes M, Naumann D, (2006) Structural differences between TSEs strains investigated by FT-IR spectroscopy. Biochim Biophys Acta 1760: 1138-1149.
15. Thomzig A, Spassov S, Friedrich M, Naumann D, Beekes M, (2004) Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J Biol Chem 279: 33847-33854.
16. Beringue V, Vilotte JL, Laude H, (2008) Prion agent diversity and species barrier. Vet Res 39: 47.
17. Collinge J, Clarke AR, (2007) A general model of prion strains and their pathogenicity. Science 318: 930-936.
18. Weissmann C, Li J, Mahal SP, Browning S, (2011) Prions on the move. EMBO Rep 12: 1109-1117.
19. Supattapone S, (2010) Biochemistry. What makes a prion infectious? Science 327: 1091-1092.
20. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, et al. (2010) The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog 6: e1000859.
21. Le Dur A, Beringue V, Andreoletti O, Reine F, Lai TL, et al. (2005) A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci U S A 102: 16031-16036.
22. Vilette D, Andreoletti O, Archer F, Madelaine MF, Vilotte JL, et al. (2001) Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci U S A 98: 4055-4059.
23. Paquet S, Langevin C, Chapuis J, Jackson GS, Laude H, et al. (2007) Efficient dissemination of prions through preferential transmission to nearby cells. J Gen Virol 88: 706-713.
24. Castilla J, Saa P, Soto C, (2005) Detection of prions in blood. Nat Med 11: 982-985.
25. Gonzalez-Montalban N, Makarava N, Savtchenko R, Baskakov IV, (2011) Relationship between conformational stability and amplification efficiency of prions. Biochemistry 50: 7933-7940.
26. London E, Brown DA, (2000) Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 1508: 182-195.
27. Rhodes DG, Bossio RE, Laue TM, (2009) Determination of size, molecular weight, and presence of subunits. Methods Enzymol 463: 691-723.
28. Huaust HL, Kuksis A, Beveridge JM, (1966) Quantitative precipitation of various 3-beta-hydroxysterols with digitonin. Can J Biochem 44: 119-128.
29. Schlosser E, (1969) Interaction of saponins with cholesterol, lecithin, and albumin. Can J Physiol Pharmacol 47: 487-490.
30. Pitha J, Irie T, Sklar PB, Nye JS, (1988) Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives. Life Sci 43: 493-502.
31. Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, et al. (2006) Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 45: 15710-15717.
32. Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, et al. (2002) Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41: 12868-12875.
33. Silva JL, Vieira TC, Gomes MP, Bom AP, Lima LM, et al. (2010) Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins. Acc Chem Res 43: 271-279.
34. Cordeiro Y, Kraineva J, Ravindra R, Lima LM, Gomes MP, et al. (2004) Hydration and packing effects on prion folding and beta-sheet conversion. High pressure spectroscopy and pressure perturbation calorimetry studies. J Biol Chem 279: 32354-32359.
35. De Simone A, Dodson GG, Verma CS, Zagari A, Fraternali F, (2005) Prion and water: tight and dynamical hydration sites have a key role in structural stability. Proc Natl Acad Sci U S A 102: 7535-7540.
36. Sargiacomo M, Scherer PE, Tang Z, Kubler E, Song KS, et al. (1995) Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci U S A 92: 9407-9411.
37. Fernandez I, Ying Y, Albanesi J, Anderson RG, (2002) Mechanism of caveolin filament assembly. Proc Natl Acad Sci U S A 99: 11193-11198.
38. Spisni E, Tomasi V, Cestaro A, Tosatto SC, (2005) Structural insights into the function of human caveolin 1. Biochem Biophys Res Commun 338: 1383-1390.
39. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, et al. (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682.
40. Fischer H, Polikarpov I, Craievich AF, (2004) Average protein density is a molecular-weight-dependent function. Protein Sci 13: 2825-2828.
41. Dron M, Moudjou M, Chapuis J, Salamat MK, Bernard J, et al. (2010) Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent. J Biol Chem 285: 10252-10264.
42. Ayers JI, Schutt CR, Shikiya RA, Aguzzi A, Kincaid AE, et al. (2011) The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog 7: e1001317.
43. Jeffrey M, McGovern G, Siso S, Gonzalez L, (2011) Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease. Acta Neuropathol 121: 113-134.
44. Cordeiro Y, Kraineva J, Gomes MP, Lopes MH, Martins VR, et al. (2005) The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation. Biophys J 89: 2667-2676.
45. Lee YH, Chatani E, Sasahara K, Naiki H, Goto Y, (2009) A comprehensive model for packing and hydration for amyloid fibrils of beta2-microglobulin. J Biol Chem 284: 2169-2175.
46. Smirnovas V, Winter R, Funck T, Dzwolak W, (2005) Thermodynamic properties underlying the alpha-helix-to-beta-sheet transition, aggregation, and amyloidogenesis of polylysine as probed by calorimetry, densimetry, and ultrasound velocimetry. J Phys Chem B 109: 19043-19045.
47. Foguel D, Suarez MC, Ferrao-Gonzales AD, Porto TC, Palmieri L, et al. (2003) Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities. Proc Natl Acad Sci U S A 100: 9831-9836.
48. Caughey B, Baron GS, (2006) Prions and their partners in crime. Nature 443: 803-810.
49. Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, et al. (2012) Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci U S A 109: E1938-1946.
50. Peterson GL, Rosenbaum LC, Schimerlik MI, (1988) Solubilization and hydrodynamic properties of pig atrial muscarinic acetylcholine receptor in dodecyl beta-D-maltoside. Biochem J 255: 553-560.
51. Lambeng N, Grossmann M, Chatelain P, Fuks B, (2006) Solubilization and immunopurification of rat brain synaptic vesicle protein 2A with maintained binding properties. Neurosci Lett 398: 107-112.
52. Siakotos AN, Gajdusek DC, Gibbs CJ Jr, Traub RD, Bucana C, (1976) Partial purification of the scrapie agent from mouse brain by pressure disruption and zonal centrifugation in sucrose-sodium chloride gradients. Virology 70: 230-237.
53. Sklaviadis T, Manuelidis L, Manuelidis EE, (1989) Physical properties of the Creutzfeldt-Jakob disease agent. J Virol 63: 1212-1222.
54. Somerville RA, Dunn AJ, (1996) The association between PrP and infectivity in scrapie and BSE infected mouse brain. Arch Virol 141: 275-289.
55. Ito J, Nagayasu Y, Kato K, Sato R, Yokoyama S, (2002) Apolipoprotein A-I induces translocation of cholesterol, phospholipid, and caveolin-1 to cytosol in rat astrocytes. J Biol Chem 277: 7929-7935.
56. Safar J, Wille H, Itri V, Groth D, Serban H, et al. (1998) Eight prion strains have PrPsc molecules with different conformations. Nat Med 4: 1157-1165.
57. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, et al. (2008) Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 416: 297-305.
58. Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, et al. (2005) Prion clearance in bigenic mice. J Gen Virol 86: 2913-2923.
59. Sajnani G, Silva CJ, Ramos A, Pastrana MA, Onisko BC, et al. (2012) PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP. PLoS Pathog 8: e1002547.
60. Berardi VA, Cardone F, Valanzano A, Lu M, Pocchiari M, (2006) Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation. Transfusion 46: 652-658.
61. Deleault AM, Deleault NR, Harris BT, Rees JR, Supattapone S, (2008) The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie. J Gen Virol 89: 2642-2650.
62. Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, et al. (2012) Small Protease Sensitive Oligomers of PrP(Sc) in Distinct Human Prions Determine Conversion Rate of PrP(C). PLoS Pathog 8: e1002835.
63. Owen JP, Rees HC, Maddison BC, Terry LA, Thorne L, et al. (2007) Molecular profiling of ovine prion diseases by using thermolysin-resistant PrPSc and endogenous C2 PrP fragments. J Virol 81: 10532-10539.
64. Masel J, Genoud N, Aguzzi A, (2005) Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer. J Mol Biol 345: 1243-1251.
65. Gonzalez-Montalban N, Baskakov IV, (2012) Assessment of strain-specific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification. PLoS One 7: e41210.
66. Jarrett JT, Lansbury PT Jr, (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058.
67. Masel J, Jansen VA, Nowak MA, (1999) Quantifying the kinetic parameters of prion replication. Biophys Chem 77: 139-152.
68. Orgel LE, (1996) Prion replication and secondary nucleation. Chem Biol 3: 413-414.
69. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, et al. (2011) Highly efficient protein misfolding cyclic amplification. PLoS Pathog 7: e1001277.
70. Leclerc E, Peretz D, Ball H, Sakurai H, Legname G, et al. (2001) Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form. EMBO J 20: 1547-1554.
71. Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, et al. (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A 103: 19105-19110.
72. Tanaka M, Collins SR, Toyama BH, Weissman JS, (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442: 585-589.
73. Eghiaian F, Daubenfeld T, Quenet Y, van Audenhaege M, Bouin AP, et al. (2007) Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage. Proc Natl Acad Sci U S A 104: 7414-7419.
74. Gosal WS, Morten IJ, Hewitt EW, Smith DA, Thomson NH, et al. (2005) Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. J Mol Biol 351: 850-864.
75. Souillac PO, Uversky VN, Millett IS, Khurana R, Doniach S, et al. (2002) Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. Evidence for an off-pathway oligomer at acidic pH. J Biol Chem 277: 12666-12679.
76. Bett C, Joshi-Barr S, Lucero M, Trejo M, Liberski P, et al. (2012) Biochemical properties of highly neuroinvasive prion strains. PLoS Pathog 8: e1002522.
77. Bellinger-Kawahara CG, Kempner E, Groth D, Gabizon R, Prusiner SB, (1988) Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da. Virology 164: 537-541.
78. Gibbs CJ Jr, Gajdusek DC, Latarjet R, (1978) Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie. Proc Natl Acad Sci U S A 75: 6268-6270.
79. Riesner D, Kellings K, Post K, Wille H, Serban H, et al. (1996) Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity. J Virol 70: 1714-1722.
80. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, et al. (2005) The most infectious prion protein particles. Nature 437: 257-261.
81. Anaya ZE, Savistchenko J, Massonneau V, Lacroux C, Andreoletti O, et al. (2011) Recovery of small infectious PrP(res) aggregates from prion-infected cultured cells. J Biol Chem 286: 8141-8148.
82. Cronier S, Carimalo J, Schaeffer B, Jaumain E, Beringue V, et al. (2012) Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death. FASEB J 26: 3854-3861.
83. Fandrich M, (2012) Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity. J Mol Biol 421: 427-440.
84. Jucker M, Walker LC, (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70: 532-540.